Prolonged neurotoxicity in a lymphoma patient after CD19‐directed CAR T‐cell therapy: A case report and brief review of the literature
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.104 ↗Kurz gefasst
Fallbericht in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Uri Greenbaum und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- University of Texas MD Anderson Cancer Center
Zitieren
APA
Greenbaum, U., Ramdial, J. L., Olson, A., Nieto, Y., Strati, P., Ahmed, S., Neelapu, S. S., Tummala, S., Chi, L., Shpall, E. J., & Kebriaei, P. (2021). Prolonged neurotoxicity in a lymphoma patient after CD19‐directed CAR T‐cell therapy: A case report and brief review of the literature. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.104
Vancouver
Greenbaum U, Ramdial JL, Olson A, Nieto Y, Strati P, Ahmed S, et al. Prolonged neurotoxicity in a lymphoma patient after CD19‐directed CAR T‐cell therapy: A case report and brief review of the literature. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.104
BibTeX
@article{Greenbaum2021,
author = {Greenbaum, Uri and Ramdial, Jeremy L. and Olson, Amanda and Nieto, Yago and Strati, Paolo and Ahmed, Sairah and Neelapu, Sattva S. and Tummala, Sudhakar and Chi, Linda and Shpall, Elizabeth J. and Kebriaei, Partow},
title = {Prolonged neurotoxicity in a lymphoma patient after CD19‐directed CAR T‐cell therapy: A case report and brief review of the literature},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.104}
}
EUVIMED